|
|
DSpace at RU >
Browsing by Title
Showing results 57789 to 57808 of 83266
| Full Text | Issue Date | Title | Author(s) |  | 2009 | Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children. | Puthanakit, T.; Lugt, J. van der; Bunupuradah, T., et al |
 | 2008 | Pharmacokinetics and 48-week efficacy of nevirapine: 400 mg versus 600 mg per day in HIV-tuberculosis coinfection receiving rifampicin. | Avihingsanon, A.; Manosuthi, W.; Kantipong, P., et al |
| | 2010 | Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial. | Musiime, V.; Kendall, L.; Bakeera-Kitaka, S., et al |
| | 1996 | Pharmacokinetics and bioavailability in male volunteers | Groot, A.N.J.A. de; Vree, T.B.; Hekster, Y.A., et al |
| | 1996 | Pharmacokinetics and bioavailability of oral methylergometrine and ergometrine in male volunteers. | Groot, A.N.J.A. de; Vree, T.B.; Hekster, Y.A., et al |
 | 1996 | Pharmacokinetics and dosimetry of cobalt-55 and cobalt-57 | Jansen, H.M.L.; Knollema, S.; Veenma van der Duin, L., et al |
| | 1996 | Pharmacokinetics and haemodynamic effects of the angiotensin converting enzyme inhibitor cilazapril in hypertensive patients with normal and impaired renal function | Kloke, H.J.; Ambros, R.J.; Hamersvelt, H.W. van, et al |
| | 2007 | Pharmacokinetics and pharmacodynamics of combined use of lopinavir/ritonavir and rosuvastatin in HIV-infected patients. | Lee, M. van der; Sankatsing, R.; Schippers, E., et al |
| | 2005 | Pharmacokinetics and pharmacodynamics of meropenem in febrile neutropenic patients with bacteremia. | Ariano, R.E.; Nyhlen, A.; Donnelly, J.P., et al |
| | 2004 | Pharmacokinetics and pharmacodynamics of meropenem in febrile neutropenic patients with bacteremia. | Ariano, R.E.; Nyhlen, A.; Donnelly, J.P., et al |
| | 2002 | Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers. | Knoester, P.D.; Jonker, D.M.; Hoeven, R.T. van der, et al |
| | 2005 | Pharmacokinetics and pharmacodynamics of rocuronium in patients with and without renal failure. | Robertson, E.N.; Driessen, J.J.; Booij, L.H.D.J. |
| | 2010 | Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients. | Bruggemann, R.J.M.; Blijlevens, N.M.A.; Burger, D.M., et al |
| | 2008 | Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adults. | Lugt, J. van der; Autar, R.S.; Ubolyam, S., et al |
| | 2007 | Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients. | Ruslami, R.; Nijland, H.M.J.; Alisjahbana, B., et al |
| | 2011 | Pharmacokinetics and toxicity of intravesical TMX-101: a preclinical study in pigs | Arentsen, H.C.; Hulsbergen- van de Kaa, C.A.; Jansen, C.F.J., et al |
| | 2004 | Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies. | Brouwers, A.H.; Mulders, P.F.A.; Oosterwijk, E., et al |
| | 2006 | Pharmacokinetics of a once-daily regimen of lopinavir/ritonavir in HIV-1-infected children. | Lee, M. van der; Verweel, G.; Groot, R. de, et al |
| | 2004 | Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteers. | Porte, C.J.L. la; Colbers, E.P.; Bertz, R., et al |
| | 2005 | Pharmacokinetics of antiretroviral therapy in HIV-1-infected children. | Fraaij, P.L.; Kampen, J.J. van; Burger, D.M., et al |
Showing results 57789 to 57808 of 83266
|
